First-line therapy for human cutaneous leishmaniasis in Peru using the TLR7 agonist imiquimod in combination with pentavalent antimony (Q28475794)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | First-line therapy for human cutaneous leishmaniasis in Peru using the TLR7 agonist imiquimod in combination with pentavalent antimony |
scientific article |
Statements
First-line therapy for human cutaneous leishmaniasis in Peru using the TLR7 agonist imiquimod in combination with pentavalent antimony (English)
0 references
28 July 2009
0 references
3
0 references
7
0 references
e491
0 references
28 July 2009
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference